Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Recruiting · NCT04134559 · Registry updated 2026-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, fibrolamellar hepatocellular carcinoma, hepatocellular carcinoma, liver cancer, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-02-24 | NCT04134559 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Allison O'Neill, MD | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 306 |
| Children's Hospital Boston | Boston | United States | 7 |
| Cincinnati Children's Medical Center | Cincinnati | United States | 2 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| University of California San Francisco | San Francisco | United States | 144 |